RSH 6.67% 2.8¢ respiri limited

Product tests & clinical results, facts please

  1. 19 Posts.
    lightbulb Created with Sketch. 7
    Richney, I am also a long term holder and very surprised to read your comments on relevant historical tests. A quick review of company releases over a long period indicates to me that

    - Airsonea, the previous version of Wheezo, never received FDA approval
    -Airsonea was never "successfully tested" against spirometry, nor has Wheezo yet
    - Airsonea achieved an 85% correlation with physicians using stethoscopes in 2016 , yet in 2020 RSH said Wheezo got only 46% in detecting wheeze before adjusting results.

    IMO you are incorrect. If you have different company information please let all of us know how to find it. That would be helpful and encouraging.

    Cheers
    Stern




 
watchlist Created with Sketch. Add RSH (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
-0.002(6.67%)
Mkt cap ! $29.67M
Open High Low Value Volume
2.9¢ 2.9¢ 2.8¢ $13.44K 464.0K

Buyers (Bids)

No. Vol. Price($)
1 196083 2.8¢
 

Sellers (Offers)

Price($) Vol. No.
3.0¢ 90348 1
View Market Depth
Last trade - 15.58pm 28/03/2024 (20 minute delay) ?
Last
2.8¢
  Change
-0.002 ( 3.45 %)
Open High Low Volume
2.9¢ 2.9¢ 2.8¢ 10880
Last updated 14.54pm 28/03/2024 ?
RSH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.